Your account is not claimed yet. You can sign up with ORCID to claim your account.

Rob Hooft van Huijsduijnen

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2016-2020
Publications (10 Years): 9

Top Venues

Malaria journal

The Journal of biological chemistry

PLoS neglected tropical diseases

Antimicrobial agents and chemotherapy

Hooft Pharma Services Sàrl

Universiteit Leiden (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Hooft Pharma Services Sàrl Feb 1o 2015

Switzerland

CEO/owner

Education History

Universiteit Leiden Sep 1o 1982 - Sep 1o 1986

Netherlands

PHD :: Biochemistry

Publications

Rob Hooft van Huijsduijnen, Somei Kojima, Dee A Carter, Hisafumi Okabe, Akihide Sato, Wataru Akahata, Timothy N C Wells, Kei Katsuno
Reassessing therapeutic antibodies for neglected and tropical diseases. PLoS neglected tropical diseases 14 (1) (2020)
Rob Hooft van Huijsduijnen, Timothy Wells, Marcel Tanner, Sergio Wittlin
Two successful decades of Swiss collaborations to develop new anti-malarials. Malaria journal 18 (1) (2019)
Jeremy Burrows, Hannah Slater, Fiona Macintyre, Sarah Rees, Anna Thomas, Fredros Okumu, Rob Hooft van Huijsduijnen, Stephan Duparc, Timothy N C Wells
A discovery and development roadmap for new endectocidal transmission-blocking agents in malaria. Malaria journal 17 (1) (2018)
Fiona Macintyre, Hanu Ramachandruni, Jeremy N Burrows, René Holm, Anna Thomas, Jörg J Möhrle, Stephan Duparc, Rob Hooft van Huijsduijnen, Brian Greenwood, Winston E Gutteridge, Timothy N C Wells, Wiweka Kaszubska
Injectable anti-malarials revisited: discovery and development of new agents to protect against malaria. Malaria journal 17 (1) (2018)
Jeremy N Burrows, Stephan Duparc, Winston E Gutteridge, Rob Hooft van Huijsduijnen, Wiweka Kaszubska, Fiona Macintyre, Sébastien Mazzuri, Jörg J Möhrle, Timothy N C Wells
Erratum to: New developments in anti-malarial target candidate and product profiles. Malaria journal 16 (1) (2017)
Emilie Alirol, Teodora Elvira Wi, Manju Bala, Maria Luiza Bazzo, Xiang-Sheng Chen, Carolyn Deal, Jo-Anne R Dillon, Ranmini Kularatne, Jutta Heim, Rob Hooft van Huijsduijnen, Edward W Hook, Monica M Lahra, David A Lewis, Francis Ndowa, William M Shafer, Liz Tayler, Kimberly Workowski, Magnus Unemo, Manica Balasegaram
Multidrug-resistant gonorrhea: A research and development roadmap to discover new medicines. PLoS medicine 14 (7) (2017)
Jeremy N Burrows, Stephan Duparc, Winston E Gutteridge, Rob Hooft van Huijsduijnen, Wiweka Kaszubska, Fiona Macintyre, Sébastien Mazzuri, Jörg J Möhrle, Timothy N C Wells
New developments in anti-malarial target candidate and product profiles. Malaria journal 16 (1) (2017)
Anita Palma, Michele Tinti, Serena Paoluzi, Elena Santonico, Bernd Willem Brandt, Rob Hooft van Huijsduijnen, Antonia Masch, Zhisheng Huang, Mike Schutkowski, Luisa Castagnoli, Gianni Cesareni
Both Intrinsic Substrate Preference and Network Context Contribute to Substrate Selection of Classical Tyrosine Phosphatases. The Journal of biological chemistry 292 (12) (2017)
James S McCarthy, Louise Marquart, Silvana Sekuloski, Katharine Trenholme, Suzanne Elliott, Paul Griffin, Rebecca Rockett, Peter O'Rourke, Theo Sloots, Iñigo Angulo-Barturen, Santiago Ferrer, María Belén Jiménez-Díaz, María-Santos Martínez, Rob Hooft van Huijsduijnen, Stephan Duparc, Didier Leroy, Timothy N C Wells, Mark Baker, Jörg J Möhrle
Linking Murine and Human Plasmodium falciparum Challenge Models in a Translational Path for Antimalarial Drug Development. Antimicrobial agents and chemotherapy 60 (6) (2016)

Rob Hooft van Huijsduijnen.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Rob Hooft van Huijsduijnen